da Silva Talita Dias, de Oliveira Patricia Mattos, Dionizio Josiane Borges, de Santana Andreia Paiva, Bahadori Shayan, Dias Eduardo Dati, Ribeiro Cinthia Mucci, Gomes Renata de Andrade, Ferreira Marcelo, Ferreira Celso, de Moraes Íbis Ariana Peña, Silva Deise Mara Mota, Barnabé Viviani, de Araújo Luciano Vieira, Santana Heloísa Baccaro Rossetti, Monteiro Carlos Bandeira de Mello
Departamento de Medicina (Cardiologia), Escola Paulista de Medicina da Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil.
Grupo de Pesquisa e Aplicações Tecnológicas em Reabilitação da Escola de Artes, Ciências e Humanidades da Universidade de São Paulo (PATER EACH USP), São Paulo, Brazil.
Front Psychol. 2021 Feb 24;12:622618. doi: 10.3389/fpsyg.2021.622618. eCollection 2021.
The new human coronavirus that leads to COVID-19 (coronavirus disease 2019) has spread rapidly around the world and has a high degree of lethality. In more severe cases, patients remain hospitalized for several days under treatment of the health team. Thus, it is important to develop and use technologies with the aim to strengthen conventional therapy by encouraging movement, physical activity, and improving cardiorespiratory fitness for patients. In this sense, therapies for exposure to virtual reality (VR) are promising and have been shown to be an adequate and equivalent alternative to conventional exercise programs. This is a study protocol with the aim of comparing the conventional physical therapy intervention with the use of a non-immersive VR software during COVID-19 hospitalization. Fifty patients hospitalized with confirmed diagnosis of COVID-19 will be divided in two groups under physiotherapy treatment using conventional or VR intervention: Group A: participants with COVID-19 will start the first day of the protocol with VR tasks in the morning and then in the second period, in the afternoon, will perform the conventional exercises ( = 25) and Group B: participants with COVID-19 will start the first day with conventional exercises in the morning and in the second period, in the afternoon, will perform activity with VR ( = 25). All participants will be evaluated with different motor and physiologic scales before and after the treatment to measure improvements. Considering the importance of benefits from physical activity during hospitalization, VR software shows promise as a potential mechanism for improving physical activity. The results of this study may provide new insights into hospital rehabilitation. ClinicalTrials.gov, identifier: NCT04537858. Registered on 01 September 2020.
导致COVID-19（2019冠状病毒病）的新型人类冠状病毒已在全球迅速传播，且具有高度致死性。在病情较为严重的情况下，患者在医疗团队的治疗下需住院数日。因此，开发和应用旨在通过鼓励患者活动、进行体育锻炼以及改善心肺功能来强化传统治疗的技术至关重要。从这个意义上讲，虚拟现实（VR）疗法颇具前景，并且已被证明是传统锻炼项目的一种合适且等效的替代方案。 这是一项研究方案，旨在比较COVID-19住院期间传统物理治疗干预与使用非沉浸式VR软件的效果。 50名确诊为COVID-19的住院患者将在接受物理治疗时分为两组，分别采用传统干预或VR干预：A组：COVID-19患者将在方案的第一天上午开始进行VR任务，然后在下午的第二阶段进行传统锻炼（n = 25）；B组：COVID-19患者将在第一天上午开始进行传统锻炼，在下午的第二阶段进行VR活动（n = 25）。所有参与者在治疗前后都将使用不同的运动和生理量表进行评估，以衡量改善情况。 考虑到住院期间体育活动带来益处的重要性，VR软件有望成为改善体育活动的潜在机制。本研究结果可能为医院康复提供新的见解。 ClinicalTrials.gov标识符：NCT04537858。于2020年9月1日注册。
